PALVELLA THERAPEUTICS INC
PVLANASDAQ🏆 #1821 by market capEarnings Nov 10US Equity
$154.67▲ $0.37 (+0.24%)
Live1h▲ 0.0%
24h▲ 0.2%
7d▲ 0.2%
14d▲ 8.4%
30d▲ 5.9%
1y▲ 258.8%
🏦Market Cap
$2.22B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
67
Fair
📊
Analyst Ratings
Price
$154.67
Total
11
Raised
1
Lowered
0
Avg PT
$231.50
H / L
$270 / $207
| Institution | Action | Rating | Date |
|---|---|---|---|
Chardan Capital | Reiterated | Buy | 2026-05-21 |
Stephens & Co. | Reiterated | Overweight | 2026-05-21 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-24 |
Mizuho | Reiterated | Outperform | 2026-02-25 |
BTIG | Reiterated | Buy | 2026-02-25 |
Canaccord Genuity | Reiterated | Buy | 2025-12-16 |
TD Cowen | Reiterated | Buy | 2025-12-16 |
Truist Securities | Reiterated | Buy | 2025-12-16 |
Stifel | Reiterated | Buy | 2025-11-24 |
Raymond James | Upgraded | Outperform → Strong Buy | 2025-11-19 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-11-06 |
One row per institution, most recent rating